AACR II: Linking HPV Infection to Skin Cancer in Patients With CLL
Immune-Mediated Adverse Events With Concomitant Radiotherapy and Immunotherapy
AACR II: Does Cyclooxygenase-2 Inhibitor Use Reduce the Risk of Skin Cancer?
AACR II: Early Tanning Bed Use and Risk for Skin Cancer
COVID-19 and Non-Melanoma Skin Cancer: Revisiting Hypofractionated Radiotherapy
Multiple Aggregated, Yellow-White Globules: Indicator of Basal Cell Carcinoma?
Non-Melanoma Skin Cancer and COVID-19: Modifications to Current Radiotherapy
Genetic Features of Virus-Positive Versus Virus-Negative Merkel Cell Carcinoma
The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment
A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer
No Elevated Cancer Risk for RA Patients With Tocilizumab
Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?
MD Anderson Cancer Center
University of California San Diego Moores Cancer Center
Memorial Sloan Kettering Cancer Center
University of Nebraska
Cetuximab (Non-Melanoma Skin Cancers)
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
The Skin Cancer Foundation
NCCN Guidelines for Patients: Squamous Cell Skin Cancer